Skip to main content

2019 | OriginalPaper | Buchkapitel

Cost-Effectiveness Analysis of Intrabeam System Introduction to the Czech Healthcare System Environment

verfasst von : Vojtěch Kamenský, Gleb Donin, Veronika Burianová, Ondřej Gajdoš, Vladimír Rogalewicz, Ivana Kubátová, Silvie Jeřábková, Peter Kneppo

Erschienen in: World Congress on Medical Physics and Biomedical Engineering 2018

Verlag: Springer Singapore

Aktivieren Sie unsere intelligente Suche um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Backround: Intrabeam system is a technology used in oncology for intraoperative radiotherapy (IORT), a technique of partial delivery of radiation therapy to the tumour bed during surgery. The aim of this study is to evaluate cost effectiveness of the Intrabeam system compared to the standard treatment with external beam radiotherapy (EBRT) in early stage breast cancer treatment in order to reach a decision on a possible introduction of the technology to the Czech healthcare system. Methods: In order to determine the clinical effects, a worldwide literature review was conducted. The cost of the Intrabeam system was estimated based on available information about acquisitions of the system worldwide in the last 5 years. The cost of treatment was calculated from the perspective of a healthcare payer, and all the information gathered was summarized in a Markov model to finalize the cost-effectiveness calculation. A sensitivity analysis was performed. Results: The input of the model was based on the TARGIT-A pragmatic randomized controlled trial—the largest and most comprehensive study among 26 selected studies from the literature review. The estimated purchase cost of the system for the Czech Republic was determined in the range of CZK 16–20 million without VAT. Based on the findings, three versions (baseline, optimistic, pessimistic) of the calculation for IORT interventions using Intrabeam were determined. In the baseline scenario, the cost of the Intrabeam system intervention was CZK 38 559, the ICER value was CZK 53 483 saved per 1 QALY lost. The results of the sensitivity analysis are consistent with the results of the baseline scenario. The ICER value is not above the cost-effectiveness threshold (currently a little above CZK 1.2 million), which is required to consider the technology cost effective. Conclusion: According to the results of the cost-effectiveness analysis, we do not currently recommend the Intrabeam system to be introduced into the Czech healthcare system.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
1.
Zurück zum Zitat Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet (London, England). 2010 Jul 10; 376(9735):91–102. Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet (London, England). 2010 Jul 10; 376(9735):91–102.
2.
Zurück zum Zitat Park CC, Yom SS, Podgorsak MB, Harris E, Price RA Jr, Bevan A, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):963–72. Park CC, Yom SS, Podgorsak MB, Harris E, Price RA Jr, Bevan A, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) Emerging Technology Committee report on electronic brachytherapy. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):963–72.
4.
Zurück zum Zitat Dušek L, Mužík J, Kubásek M, Koptíková J, Žaloudík J, Vyzula R, et al. Epidemiology of malignant tumors in the Czech Republic (Epidemiologie zhoubných nádorů v České republice) [Internet web page; cited 2016 Dec 30]. Version 7.0. Available from: http://www.svod.cz. Dušek L, Mužík J, Kubásek M, Koptíková J, Žaloudík J, Vyzula R, et al. Epidemiology of malignant tumors in the Czech Republic (Epidemiologie zhoubných nádorů v České republice) [Internet web page; cited 2016 Dec 30]. Version 7.0. Available from: http://​www.​svod.​cz.
5.
Zurück zum Zitat Deneve JL, Hoefer RA, Harris EER, Laronga C. Accelerated partial breast irradiation: a review and description of an early North American surgical experience with the intrabeam delivery system. Cancer Control. 2012 Oct; 19(4):295–308. Deneve JL, Hoefer RA, Harris EER, Laronga C. Accelerated partial breast irradiation: a review and description of an early North American surgical experience with the intrabeam delivery system. Cancer Control. 2012 Oct; 19(4):295–308.
7.
Zurück zum Zitat Picot J, Copley V, Colquitt JL, Kalita N, Hartwell D, Bryant J. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation. Health Technol Assess (Rockv). 2015; 19(69):1–190. Picot J, Copley V, Colquitt JL, Kalita N, Hartwell D, Bryant J. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation. Health Technol Assess (Rockv). 2015; 19(69):1–190.
10.
Zurück zum Zitat Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet (London, England). 2014 Feb 15; 383(9917):603–13. Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet (London, England). 2014 Feb 15; 383(9917):603–13.
11.
Zurück zum Zitat Engel D, Schnitzer A, Brade J, Blank E, Wenz F, Suetterlin M, et al. Are Mammographic Changes in the Tumor Bed More Pronounced After Intraoperative Radiotherapy for Breast Cancer? Subgroup Analysis from a Randomized Trial. Breast J. 2013 Jan; 19(1):92–5. Engel D, Schnitzer A, Brade J, Blank E, Wenz F, Suetterlin M, et al. Are Mammographic Changes in the Tumor Bed More Pronounced After Intraoperative Radiotherapy for Breast Cancer? Subgroup Analysis from a Randomized Trial. Breast J. 2013 Jan; 19(1):92–5.
12.
Zurück zum Zitat Elsberger B, Romsauerova A, Vinnicombe S, Whelehan P, Brown DC, Dewar JA, et al. Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy. Eur J Surg Oncol. 2014 Feb; 40(2):163–7. Elsberger B, Romsauerova A, Vinnicombe S, Whelehan P, Brown DC, Dewar JA, et al. Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapy. Eur J Surg Oncol. 2014 Feb; 40(2):163–7.
13.
Zurück zum Zitat Keshtgar MRS, Vaidya JS, Tobias JS, Wenz F, Joseph D, Stacey C, et al. Targeted Intraoperative Radiotherapy for Breast Cancer in Patients in Whom External Beam Radiation Is Not Possible. Int J Radiat Oncol. 2011 May; 80(1):31–8. Keshtgar MRS, Vaidya JS, Tobias JS, Wenz F, Joseph D, Stacey C, et al. Targeted Intraoperative Radiotherapy for Breast Cancer in Patients in Whom External Beam Radiation Is Not Possible. Int J Radiat Oncol. 2011 May; 80(1):31–8.
14.
Zurück zum Zitat Keshtgar MMRS, Williams NRN, Bulsara M, Saunders C, Flyger H, Cardoso JS, et al. Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial. Breast cancer Res. 2013 Aug; 140(3):519–25. Keshtgar MMRS, Williams NRN, Bulsara M, Saunders C, Flyger H, Cardoso JS, et al. Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial. Breast cancer Res. 2013 Aug; 140(3):519–25.
15.
Zurück zum Zitat Sperk E, Welzel G, Keller A, Kraus-Tiefenbacher U, Gerhardt A, Sütterlin M, et al. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. Breast Cancer Res Treat. 2012 Aug; 135(1):253–60. Sperk E, Welzel G, Keller A, Kraus-Tiefenbacher U, Gerhardt A, Sütterlin M, et al. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A. Breast Cancer Res Treat. 2012 Aug; 135(1):253–60.
16.
Zurück zum Zitat Tuschy B, Berlit S, Romero S, Sperk E, Wenz F, Kehl S, et al. Clinical aspects of intraoperative radiotherapy in early breast cancer: short-term complications after IORT in women treated with low energy x-rays. Radiat Oncol. 2013 Jan; 8:95. Tuschy B, Berlit S, Romero S, Sperk E, Wenz F, Kehl S, et al. Clinical aspects of intraoperative radiotherapy in early breast cancer: short-term complications after IORT in women treated with low energy x-rays. Radiat Oncol. 2013 Jan; 8:95.
17.
Zurück zum Zitat Welzel G, Hofmann F, Blank E, Kraus-Tiefenbacher U, Hermann B, Sütterlin M, et al. Health-related quality of life after breast-conserving surgery and intraoperative radiotherapy for breast cancer using low-kilovoltage X-rays. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:359–67. Welzel G, Hofmann F, Blank E, Kraus-Tiefenbacher U, Hermann B, Sütterlin M, et al. Health-related quality of life after breast-conserving surgery and intraoperative radiotherapy for breast cancer using low-kilovoltage X-rays. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:359–67.
18.
Zurück zum Zitat Welzel G, Boch A, Sperk E, Hofmann F, Kraus-Tiefenbacher U, Gerhardt A, et al. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A. Radiat Oncol. 2013 Jan; 8:9. Welzel G, Boch A, Sperk E, Hofmann F, Kraus-Tiefenbacher U, Gerhardt A, et al. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A. Radiat Oncol. 2013 Jan; 8:9.
26.
Zurück zum Zitat Bartelink H. Intraoperative radiotherapy for breast cancer: tail wagging the dog? Lancet Oncol. 2004 Apr; 5(4):207–8. Bartelink H. Intraoperative radiotherapy for breast cancer: tail wagging the dog? Lancet Oncol. 2004 Apr; 5(4):207–8.
27.
Zurück zum Zitat Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013 Dec;14(13):1269–77. Veronesi U, Orecchia R, Maisonneuve P, Viale G, Rotmensz N, Sangalli C, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol. 2013 Dec;14(13):1269–77.
28.
Zurück zum Zitat Kreike B, Hart AAM, van de Velde T, Borger J, Peterse H, Rutgers E, et al. Continuing Risk of Ipsilateral Breast Relapse After Breast-Conserving Therapy at Long-Term Follow-up. Int J Radiat Oncol. 2008; 71(4):1014–21. Kreike B, Hart AAM, van de Velde T, Borger J, Peterse H, Rutgers E, et al. Continuing Risk of Ipsilateral Breast Relapse After Breast-Conserving Therapy at Long-Term Follow-up. Int J Radiat Oncol. 2008; 71(4):1014–21.
29.
Zurück zum Zitat Shah C, Lanni TB, Saini H, Nanavati A, Wilkinson J Ben, Badiyan S, et al. Cost-efficacy of acceleration partial-breast irradiation compared with whole-breast irradiation. Breast Cancer Res Treat. 2013 Feb; 138(1):127–35. Shah C, Lanni TB, Saini H, Nanavati A, Wilkinson J Ben, Badiyan S, et al. Cost-efficacy of acceleration partial-breast irradiation compared with whole-breast irradiation. Breast Cancer Res Treat. 2013 Feb; 138(1):127–35.
30.
Zurück zum Zitat Alvarado MD, Mohan AJ, Esserman LJ, Park CC, Harrison BL, Howe RJ, et al. Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol. 2013 Sep; 20(9):2873–80. Alvarado MD, Mohan AJ, Esserman LJ, Park CC, Harrison BL, Howe RJ, et al. Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol. 2013 Sep; 20(9):2873–80.
31.
Zurück zum Zitat Grobmyer SR, Lightsey JL, Bryant CM, Shaw C, Yeung A, Bhandare N, et al. Low-kilovoltage, single-dose intraoperative radiation therapy for breast cancer: results and impact on a multidisciplinary breast cancer program. J Am Coll Surg. 2013 Apr; 216(4):617-23-4. Grobmyer SR, Lightsey JL, Bryant CM, Shaw C, Yeung A, Bhandare N, et al. Low-kilovoltage, single-dose intraoperative radiation therapy for breast cancer: results and impact on a multidisciplinary breast cancer program. J Am Coll Surg. 2013 Apr; 216(4):617-23-4.
32.
Zurück zum Zitat Williams NR, Pigott KH, Brew-Graves C, Keshtgar MRS. Intraoperative radiotherapy for breast cancer. Gland Surg. 2014 May; 3(2):109–19. Williams NR, Pigott KH, Brew-Graves C, Keshtgar MRS. Intraoperative radiotherapy for breast cancer. Gland Surg. 2014 May; 3(2):109–19.
Metadaten
Titel
Cost-Effectiveness Analysis of Intrabeam System Introduction to the Czech Healthcare System Environment
verfasst von
Vojtěch Kamenský
Gleb Donin
Veronika Burianová
Ondřej Gajdoš
Vladimír Rogalewicz
Ivana Kubátová
Silvie Jeřábková
Peter Kneppo
Copyright-Jahr
2019
Verlag
Springer Singapore
DOI
https://doi.org/10.1007/978-981-10-9038-7_19

Neuer Inhalt